Chemogenetic approaches reveal dual functions of microglia in seizures

Copyright © 2023 Elsevier Inc. All rights reserved..

Microglia are key players in maintaining brain homeostasis and exhibit phenotypic alterations in response to epileptic stimuli. However, it is still relatively unknown if these alterations are pro- or anti-epileptic. To unravel this dilemma, we employed chemogenetic manipulation of microglia using the artificial Gi-Dreadd receptor within a kainic acid (KA) induced murine seizure model. Our results indicate that acute Gi-Dreadd activation with Clozapine-N-Oxide can reduce seizure severity. Additionally, we observed increased interaction between microglia and neuronal soma, which correlated with reduced neuronal hyperactivity. Interestingly, prolonged activation of microglial Gi-Dreadds by repeated doses of CNO over 3 days, arrested microglia in a less active, homeostatic-like state, which associated with increased neuronal loss after KA induced seizures. RNAseq analysis revealed that prolonged activation of Gi-Dreadd interferes with interferon β signaling and microglia proliferation. Thus, our findings highlight the importance of microglial Gi signaling not only during status epilepticus (SE) but also within later seizure induced pathology.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:115

Enthalten in:

Brain, behavior, and immunity - 115(2024) vom: 20. Jan., Seite 406-418

Sprache:

Englisch

Beteiligte Personen:

Dheer, Aastha [VerfasserIn]
Bosco, Dale B [VerfasserIn]
Zheng, Jiaying [VerfasserIn]
Wang, Lingxiao [VerfasserIn]
Zhao, Shunyi [VerfasserIn]
Haruwaka, Koichiro [VerfasserIn]
Yi, Min-Hee [VerfasserIn]
Barath, Abhijeet [VerfasserIn]
Tian, Dai-Shi [VerfasserIn]
Wu, Long-Jun [VerfasserIn]

Links:

Volltext

Themen:

Anticonvulsants
Chemogenetics
Gi-Dreadds
Hippocampus
Journal Article
Kainic Acid
Kainic acid
Microglia
Research Support, N.I.H., Extramural
SIV03811UC
Seizures

Anmerkungen:

Date Completed 16.12.2023

Date Revised 27.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.bbi.2023.11.002

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364179783